NVAX Past Earnings image   This NVAX past earnings page last updated 5/23/2022
NVAX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/9/20222.560
Q4 20212/28/2022-11.180
Q3 202111/4/2021-4.310
Q2 20218/5/2021-4.750
Q1 20215/10/2021-3.050
Q4 20203/1/2021-2.700
Q3 202011/9/2020-3.210
Q2 20208/10/2020-0.300
Q1 20205/11/2020-0.580
Q4 20193/11/2020-1.130
Q3 201911/7/2019-0.740
Q2 20198/7/2019-1.690
Q1 20195/2/2019-2.200
Q4 20183/18/2019-2.600
Q3 201811/7/2018-2.400
Q2 20188/8/2018-2.400
Q1 20185/9/2018-2.800
Q4 20173/14/2018-3.200
Q3 201711/7/2017-3.000
Q2 20178/8/2017-3.200
Q1 20175/8/2017-3.200
Q4 20162/27/2017-4.200
Q3 201611/9/2016-4.800
Q2 20168/9/2016-5.800
Q1 20165/4/2016-5.800
Q4 20152/29/2016-5.800
Q3 201511/9/2015-2.400
Q2 20158/10/2015-1.600
Q1 20155/7/2015-2.000
Q4 20142/26/2015-2.600
Q3 201411/5/2014-1.600
Q2 20148/6/2014-1.600
Q1 20145/7/2014-1.400
Q4 20133/10/2014-1.400
Q3 201311/7/2013-1.800
Q2 20138/8/2013-1.600
Q1 20135/7/2013-1.400
Q4 20123/1/2013-1.200
Q3 201211/5/2012-1.000
Q2 20128/9/2012-1.000
Q1 20125/3/2012-1.200
NVAX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/9/20220.70B
Q4 20212/28/20220.22B
Q3 202111/4/20210.18B
Q2 20218/5/20210.30B
Q1 20215/10/20210.45B
Q4 20203/1/20210.28B
Q3 202011/9/20200.16B
Q2 20208/10/20200.04B
Q1 20205/11/20200.00B
Q4 20193/11/20200.01B
Q3 201911/7/20190.00B
Q2 20198/7/20190.00B
Q1 20195/2/20190.00B
Q4 20183/18/20196.13M
Q3 201811/7/20187.74M
Q2 20188/8/201810.77M
Q1 20185/9/20189.65M
Q4 20173/14/201810.41M
Q3 201711/7/20178.35M
Q2 20178/8/20176.73M
Q1 20175/8/20175.68M
Q4 20162/27/20175.40M
Q3 201611/9/20163.23M
Q2 20168/9/20162.50M
Q1 20165/4/20164.22M
Q4 20152/29/20165.85M
Q3 201511/9/20156.53M
Q2 20158/10/201514.00M
Q1 20155/7/20159.88M
Q4 20142/26/20156.72B
Q3 201411/5/20148.21M
Q2 20148/6/20148.26M
Q1 20145/7/20147.46M
Q4 20133/10/20148.75M
Q3 201311/7/20134.80M
Q2 20138/8/20133.53M
Q1 20135/7/20133.83M
Q4 20123/1/20134.57M
Q3 201211/5/20125.76M
Q2 20128/9/20120.01B
Q1 20125/3/20124.64M
Quotes delayed 20 minutes

Email EnvelopeFree NVAX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Novavax (NVAX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NVIV Historical Earnings
NVNO Historical Earnings
NVOS Historical Earnings
NVRO Historical Earnings
NVST Historical Earnings
NVTA Historical Earnings
NXTC Historical Earnings
OCGN Historical Earnings
OCUL Historical Earnings
OCUP Historical Earnings

NVAX Past Earnings Q&A

What was the best and worst NVAX past earnings results?
For Novavax, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NVAX past earnings result in our data set was 2.560/share posted in Q1 2022, while the lowest was in Q4 2021 when NVAX posted -11.180/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2014 when NVAX reported 6.72B in revenue, while the quarter with the lowest revenue in our data set was Q2 2016 at 2.50M of revenue.

  Suggested answer: There are 41 NVAX past earnings results in our data set.

On this page we presented the NVAX past earnings date information for Novavax. Reviewing that NVAX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2022, when NVAX posted gaap of 2.560/share. Meanwhile the lowest NVAX past earnings result was in Q4 2021, when NVAX posted gaap of -11.180/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2014 when NVAX reported 6.72B in revenue, while the smallest revenue quarter was Q2 2016 when NVAX reported 2.50M in revenue.

Any self directed investor doing their due diligence on NVAX or any other given stock can benefit from researching all of the Novavax past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Novavax past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NVAX. Thanks for visiting, and the next time you need to research NVAX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Funds Holding DESC, Top Ten Hedge Funds Holding ADMP, TAP Videos.

 

NVAX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.